Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a correction. Please see:

Correction: Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis - October 01, 2021

PDF +
Supplementary
Material

XML

Clinical/translational cancer immunotherapy

Original research

Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis

Online download statistics by month:

Online download statistics by month: August 2021 to March 2024

	Abstract	Full	Pdf
Aug 2021	120	121	26
Sep 2021	444	445	177
Oct 2021	268	268	63
Nov 2021	161	160	56
Dec 2021	118	118	29
Jan 2022	110	111	47
Feb 2022	101	101	50
Mar 2022	58	59	25
Apr 2022	83	85	31
May 2022	77	81	41
Jun 2022	79	82	28
Jul 2022	82	84	33
Aug 2022	97	99	22
Sep 2022	105	105	32
Oct 2022	120	121	45
Nov 2022	87	89	24
Dec 2022	94	94	38
Jan 2023	89	89	29
Feb 2023	108	108	44
Mar 2023	85	86	45
Apr 2023	62	62	26
May 2023	83	83	26
Jun 2023	54	54	14
Jul 2023	22	22	16
Aug 2023	29	29	20
Sep 2023	28	28	18
Oct 2023	36	36	24
Nov 2023	43	43	15
Dec 2023	54	54	26
Jan 2024	53	54	29
Feb 2024	38	38	27
Mar 2024	41	41	96
Total	3029	3050	1222